Lactobacillus acidophilus – LA02 (DSM 21717)
Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus acidophilus – LA02 (DSM 21717) Read More »
Parkinson's disease
Lactobacillus plantarum – LP01 (LMG P-21021)
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus plantarum – LP01 (LMG P-21021) Read More »
Lactobacillus rhamnosus – LR06 (DSM 21981)
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus rhamnosus – LR06 (DSM 21981) Read More »
Lactobacillus salivarius – LS01 (DSM 22775)
Treatment of atopic dermatitis • Improvement of the Quality of Life in subjects with Atopic Dermatitis • Skin health • Inhibition of C. acnes (formerly classified as P. acnes) – induced IL-8 release. Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus salivarius – LS01 (DSM 22775) Read More »
